Global Medication Management Market Set To Grow To $2.0 In 2022
06 August 2018
Visiongain has launched a new pharma report Global Medication Management Market to 2027: System & Software, Services, Mode of Delivery, Computerised Physician Order Entry, Clinical Decision Support System, Medication Administration Software, Automated Dispensing System, Medication Analytics, Point of Care Verification, Adverse Drug Event Surveillance
The future of the medication management market looks promising, as more and more healthcare providers adopt medication management solutions to reduce the complications in drug administration. Medication management systems are used in hospitals and pharmacies for the prescribing and administering of medicines. Demand for advanced healthcare information and remote patient monitory will propel the medication management market.
The lead analyst of the report commented - “The global medication management market will see steady growth over the forecast period. Growth in the market is primarily driven by the increasing adoption of medication management solutions by hospitals and pharmacies to reduce medication errors, increase in number of prescriptions and increased health care expenditure. However, high costs associated with implementing software and timely gradation and maintenance of these systems may deplete the market to a certain extent.
Asia Pacific is expected to experience the fastest growth owing to large population pool, increased prevalence of infectious diseases, and continued commitment by the government and healthcare providers for better healthcare services.’’
Leading companies featured in the report include Cerner Corporation, GE Healthcare, Epic Systems Corporation, Allscripts Healthcare Solutions, McKesson Corporation, Siemens AG, Braun Melsungen AG, Oracle Corporation, Qualcomm Incorporated, Becton, Dickinson and Company.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100
About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Recent News
Visiongain Publishes Biologics Market Report 2024-2034
The biologics market is estimated at US$447 billion in 2023 and is projected to grow at a CAGR of 8.5% during the forecast period 2024-2034.
20 November 2023
Read
Visiongain Publishes mRNA Vaccines Market Report 2023-2033
The global mRNA Vaccines market is estimated at US$11,773.3 million in 2023 and is projected to grow at a CAGR of 10.5% during the forecast period 2023-2033.
08 November 2023
Read
Visiongain Publishes Stem Cell Technologies and Applications Market Report 2023-2033
The global Stem Cell Technologies and Applications market is estimated at US$10,059.6 million in 2023 and is projected to grow at a CAGR of 8.7% during the forecast period 2023-2033.
06 November 2023
Read
Visiongain Publishes Neurology Clinical Trials Market Report 2023-2033
The global Neurology Clinical Trials market is valued at US$9,609.2 million in 2023 and is projected to grow at a CAGR of 5.4% during the forecast period 2023-2033.